We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA UPHOLDS AUTHORIZED GENERICS, LAWSUITS LIKELY TO FOLLOW
FDA UPHOLDS AUTHORIZED GENERICS, LAWSUITS LIKELY TO FOLLOW
July 27, 2004
The FDA has refused to prohibit the marketing and distribution of brand-authorized generic drugs during another generic firm’s 180-day exclusivity period for the same product — a move that will likely prompt a lawsuit against the agency.